Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors (Q40692830)

22 September 2017

title

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors (English)

1 reference

22 September 2017

Sergei Zolotukhin

1

1 reference

22 September 2017

Mark Potter

2

1 reference

22 September 2017

Irene Zolotukhin

3

1 reference

22 September 2017

Yoshihisa Sakai

4

1 reference

22 September 2017

Scott Loiler

5

1 reference

22 September 2017

Thomas J Fraites

6

1 reference

22 September 2017

Vince A Chiodo

7

1 reference

22 September 2017

Tina Phillipsberg

8

1 reference

22 September 2017

Nicholas Muzyczka

9

1 reference

22 September 2017

William W Hauswirth

10

1 reference

22 September 2017

Terance R Flotte

11

1 reference

22 September 2017

Barry J Byrne

12

1 reference

22 September 2017

Richard O Snyder

13

1 reference

22 September 2017

publication date

1 October 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

28

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

158-167

1 reference

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Site-specific integration by adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Targeted integration of adeno-associated virus (AAV) into human chromosome 19

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

The kinetics of rAAV integration in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Development of animal models for adeno-associated virus site-specific integration

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Adeno-associated virus site-specifically integrates into a muscle-specific DNA region

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Streamlined large-scale production of recombinant adeno-associated virus (rAAV) vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Recombinant adeno-associated viral vector production using stable packaging and producer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Cell lines for the production of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Novel tools for production and purification of recombinant adenoassociated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Adeno-associated virus vectors can be efficiently produced without helper virus

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Role for highly regulated rep gene expression in adeno-associated virus vector production

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Adeno-associated virus general transduction vectors: analysis of proviral structures

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Hepatic "stem" cells: coming full circle

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease).

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Bone marrow as a potential source of hepatic oval cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900220-7

7 January 2021

10.1016/S1046-2023(02)00220-7

Identifiers

DOI

1 reference

22 September 2017

1 reference